Melatonin and Alzheimer's Disease

dc.contributor.author	Abdullayeva N.N
dc.contributor.author	Kasimov A.A.
dc.contributor.author	Eshpo’latov Sh. S.
dc.contributor.author	Norbekov B. Sh.
dc.date.accessioned	2025-12-31T12:15:24Z
dc.date.issued	2023-06-30
dc.description.abstract	Alzheimer's disease (AD) is the most common cause of severe cognitive impairment in old age among organic brain lesions. Given the progressive aging of the population in industrialized countries and the increasing number of people suffering from AD, the problem of its pathogenesis and treatment becomes not only of medical, but also of social importance.
dc.format	application/pdf
dc.identifier.uri	https://scholarsdigest.org/index.php/ijsnms/article/view/314
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/44871
dc.language.iso	eng
dc.publisher	Scholars Digest Publishing
dc.relation	https://scholarsdigest.org/index.php/ijsnms/article/view/314/306
dc.source	International Journal of Studies in Natural and Medical Sciences; Vol. 2 No. 6 (2023); 104-114
dc.source	2949-8848
dc.source	2949-8953
dc.subject	Alzheimer's disease, epiphysis, melatonin.
dc.title	Melatonin and Alzheimer's Disease
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail